false 0001757715 0001757715 2023-09-13 2023-09-13
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 or 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 13, 2023
 
Aterian, Inc.
(Exact Name of Registrant as Specified in its Charter) 
 
Delaware
  
001-38937
  
83-1739858
(State or Other Jurisdiction
of Incorporation)
  
(Commission
File Number)
  
(IRS Employer
Identification No.)
 
Aterian, Inc.
350 Springfield Avenue, Suite #200
Summit, NJ 07901
(Address of Principal Executive Offices)(Zip Code)
(347) 676-1681
(Registrant’s telephone number, including area code)
N/A
(Former Name, or Former Address, if Changed Since Last Report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities Registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading Symbol
  
Name of each exchange on which registered
Common Stock, $0.0001 par value
  
ATER
  
The Nasdaq Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☒
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
Item 5.02  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
 
Effective September 13, 2023, Aterian, Inc. (the “Company”) made certain changes to the compensation arrangements for each of Joseph A. Risico, Co-Chief Executive Officer, and Arturo Rodriguez, Co-Chief Executive Officer and Chief Financial Officer as follows pursuant to amendments to their employment agreements with the Company (the “Amendments”):
 
o         each of Messrs. Risico and Rodriguez
 
-         received an increase in base salary to $325,000 per annum; and
 
-         was granted 945,946 shares of restricted common stock of the Company, vesting one-third on the one-year anniversary of the date of grant and thereafter in eight equal quarterly installments.
 
          In addition, in the event Mr. Risico or Mr. Rodriguez is terminated from employment by the Company other than for Cause (as defined in the Amendments), contingent upon their execution and delivery of an effective release agreement in a form provided by the Company (a “Release”), he will receive
 
-         severance consisting of twelve months’ base salary payable under the Company’s normal payroll practices;
 
-         payment of COBRA insurance premiums for twelve months from the date of termination or until the date of commencement of employment with another; and
 
-         acceleration of unvested equity awards.
 
Also, in the event of a Change in Control of the Company (as defined in the Company’s 2019 Equity Plan, as amended) followed by Mr. Risico or Mr. Rodriguez resigning from the Company for good reason (as defined in the Amendments) within 12 months following a Change in Control, he will receive the above-listed benefits, contingent upon their execution and delivery of a Release.
A copy of the Amendments will be filed as exhibits to the Form 10-Q for the three months ended September 30, 2023. The foregoing summary is qualified in its entirety by reference to the full text of such exhibits.
 
Item 9.01. Financial Statements and Exhibits.
 
(d) Exhibits
 
 
Number Description
104 Cover Page Interactive Data File (embedded within the Inline XBRL)
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
ATERIAN, INC.
  
       
       
Date:  September 18, 2023
By:
/s/ Joseph A. Risico
  
   
Name: Joseph A. Risico
  
   
Title: Co-Chief Executive Officer
  
 
 
v3.23.3
Document And Entity Information
Sep. 13, 2023
Document Information [Line Items]  
Entity, Registrant Name Aterian, Inc.
Document, Type 8-K
Document, Period End Date Sep. 13, 2023
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-38937
Entity, Tax Identification Number 83-1739858
Entity, Address, Address Line One 350 Springfield Avenue, Suite #200
Entity, Address, City or Town Summit
Entity, Address, State or Province NJ
Entity, Address, Postal Zip Code 07901
City Area Code 347
Local Phone Number 676-1681
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol ATER
Security Exchange Name NASDAQ
Entity, Emerging Growth Company true
Entity, Ex Transition Period false
Amendment Flag false
Entity, Central Index Key 0001757715
Aterian (NASDAQ:ATER)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Aterian Charts.
Aterian (NASDAQ:ATER)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Aterian Charts.